Compulsory vaccina0on and rates of coverage immunisa0on in Europe

Similar documents
Preven&ng Pertussis: Current and Needed Strategies. June 16, PM 8PM

WP4 Communica.on analysis. Murcia, 30 May 2014

Monthly measles and rubella monitoring report

Preven&ng Pertussis: Current and Needed Strategies June 16, PM 8PM

Measles and rubella monitoring January 2015

Opinion. Vaccination Programmes and Health Systems in the EU. Expert Panel on Effective Ways of Investing in Health

WHO position paper on rubella vaccines

TRAVEL MEDICINE INFORMATION SERVICE MODEL

Partnering with school- based. providers to improve HPV immunisa5on uptake in Victoria, Australia. Heather O Donnell December 2014

OVERVIEW 2018 VACCINE UPDATE 3/19/ VACCINE SCHEDULE

Measles susceptibility of selected cohorts in EU countries

Afghanistan: WHO and UNICEF estimates of immunization coverage: 2017 revision

Annotated Bibliography:

Immunization Program Resources: Planning and Forecasting Immunization Program Managers Meeting Atlanta, Georgia July 11, 2014

SHOULD VACCINES BE COMPULSORY?

Seasonal influenza vaccination Recommendations & Reality

MedInform. Ethical and healthcare considerations in relation to mandatory vaccination - Bulgarian perspective. Literature Review

Pakistan: WHO and UNICEF estimates of immunization coverage: 2017 revision

Summary Report EU Health Award 2017

Mandatory Influenza Vaccination for Healthcare Personnel

Mandates and More. Julie Morita, M.D. Deputy Commissioner Chicago Department of Public Health. Chicago Department of Public Health

In this module we will cover Correla4on and Validity.

Vaccine hesitancy in the EU: state of play and impact on vaccination programmes

Perspectives from regions: successes and challenges in promoting seasonal influenza vaccine usage in the EU

EUVAC.NET A surveillance network for vaccine-preventable diseases

WHO posi)on paper on influenza vaccines*

ASF Socio Economic impact Vaccine and vaccina2on. Vi3orio Guber2 ISPRA, Italy

Outbreak! Pandemic! Panic!

CHAPTER 23 IMMUNIZATION AND VACCINE DISTRIBUTION

GLOBAL IMMUNIZATION COVERAGE IN 2016

The Italian decision to mandate. children vaccinations. Fortunato D Ancona, MD Italian Ministry of Health

HPROIMMUNE PROMOTION OF IMMUNIZATION FOR HEALTH PROFESSIONALS IN EUROPE STATE OF THE ART REPORT

Establishing a second-year-of-life (2YL) healthy child visit

Table 1: Basic information Total population 25,030, (per 100,000 LB) Division/Province/State/Region 11. District 210

Strategies to address vaccine hesitancy:

Public Health Wales Vaccine Preventable Disease Programme

European monthly measles monitoring (EMMO)

WHO posi)on paper on pneumococcal vaccines. Geneva, Switzerland Published in the Weekly Epidemiological Record on 6 Apr 2012

Legislative Approaches to Immunization Across the European Region

Case Studies in Ecology and Evolution. 10 The population biology of infectious disease

National seasonal influenza vaccination programmes in Europe

Dispelling the Myths and Rumors of Immunization. September 15, 2016

The Gates Challenge. Bill Gates Commencement Address Harvard University Class of 2007

Nigeria: WHO and UNICEF estimates of immunization coverage: 2017 revision

Drug laws, penalties and alternatives across Europe


NHS public health functions agreement Service specification No.9 DTaP/IPV and dtap/ipv pre-school booster immunisation programme

Vaccination: obligation or choice?

Global and National Trends in Vaccine Preventable Diseases. Dr Brenda Corcoran National Immunisation Office.

Ethics and Boundaries

VACCINES TRIUMPHS AND TRIBULATIONS. William Schaffner, MD Chairman, Department of Preventive Medicine Vanderbilt University School of Medicine

Proof of residency in East Orange is mandatory (see Residency Requirements)

School-based HPV Immunisation Programs: The WA Experience

The State of Measles and Rubella in the WHO European Region

Update on Mumps, Pertussis, and Hepatitis A Morbidity Los Angeles County

1. Executive Summary 2. Worldwide Pediatric Vaccines Market and Forecast ( ) 3. Worldwide Pediatric Vaccines Market Share & Forecast (Sector

The Danish childhood vaccination program SUMMARY IN ENGLISH

Table 1: Basic information (per 1,000 LB) 42.4 (per 1,000 LB) 49.7 (per 1,000 LB) 215 (per 100,000 LB)

Proposal for an EU Joint Action on Vaccination: Cross-border challenges to be addressed

WHO/UNICEF Review of National Immunization Coverage India

Langston University Student Health Services Policies and Forms October 3, 2016

TELL ME Communication Kit

Global Immunizations & UNICEF s Role Dr. Robin Nandy Principal Advisor & Chief of Immunizations UNICEF Headquarters

Let s talk about protection Childhood Vaccination. Flipbook to support conversations with parents and caregivers

Giovanni Rezza: Mandatory vaccinations in Italy scientific evidence and political...

Below you will find information about diseases, the risk of contagion, and preventive vaccinations.

Vaccine Innovation: Challenges and Opportunities to Protect Health. Julie Louise Gerberding, M.D., M.P.H President, Merck Vaccines

Shabir A. Madhi. Progress and Challenges of Immunization Contributing Toward Attaining the MDG Goal to Reduce under-5 Childhood Mortality.

The challenge of vaccine hesitancy in the European Union

How do we sustain acceptance in societies with mandates: The situation in Germany

Adverse Event Following Immunization (AEFI)

Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA

Outbreak response in post- OPV2 withdrawal era. Strategic Advisory Group of Experts (SAGE) on immuniza;on, Geneva, 22 October 2014

Written by Arlan Cage, ND, Lac Thursday, 01 March :00 - Last Updated Thursday, 26 February :39

Palliative Care: European Experience

The Changing Face of Childhood Vaccination. Dr Terry Coll National Immunisation Meeting 16 th April 2007

Information resources for healthcare professionals on immunisation schedules and vaccines in EU countries

Ethics and Boundaries

Vaccinology Overview. Complexity of the Vaccine Approval Process Including Lessons Learned

achievements, challenges and financing

An Insight into the Immunization Coverage for Combined Vaccines in Albania

Table 1: Basic information 2017

School Vaccination Assessment Program (SVAP):

Immunize. Prevent what s preventable Stakeholder Mee1ng.

TABLE OF CONTENTS. In what way can this educational material help me? Why are vaccinations important? Who needs vaccinations?

HEALTH INFORMATION FORM

COMMISSION OF THE EUROPEAN COMMUNITIES

Targeted Diseases and Immunization. Strategic plan

Smokefree Policies in Europe: Are we there yet?

Immunization coverage and exemptions among Ontario s school pupils for : Findings and implications for future information systems

Back to Basics: Regional Progress Towards Measles and Rubella Elimination and Introduction of New Vaccines WHO European Regional Office

Adult Immuniza-on Update

Student Immunization Record Part I Student Information

National seasonal influenza vaccination programmes in Europe

The Financial Sustainability of New Vaccine Introduction in the Poorest Countries :

Underage drinking in Europe

APPENDIX EE VACCINE STATUS AND DATE

The Johns Hopkins Vaccine Initiative Johns Hopkins Bloomberg School of Public Health

Sign Language Act in Europe and Hungary by dr. Ádám Kósa

Transcription:

ASSET dataviz 1 p1 Compulsory vaccina0on and rates of coverage immunisa0on in Europe Introduc)on High rates of vaccina0on coverage in childhood are main indicators for public health. However, reaching and maintaining such a target is not always an easy task for public health ins0tu0ons, and the spread of vaccine refusal and hesitancy is making this even harder. Enforcing mandatory vaccina0ons is one of the strategies that some countries adopted and others are considering in order to face this issue. Depending on local legisla0ons, legal consequences for those who do not accept the uptake can be very different, ranging from pecuniary penal0es to hurdles to a@end public schools. In some cases, parents may even incur penal consequences, as it recently happened in France, were two parents refusing to vaccinate their children risked a jail sentence. Nevertheless, the efficacy of such an approach has been ques0oned. ASSET performed an analysis on the issue, comparing coverage rates of immunisa0on against polio (Pol3), measles (MCV1) and pertussis containing vaccines (DTP3)* in European Union/European Economic Area (EU/EEA) countries, where, according to different policies, these vaccina0ons are either mandatory or recommended. This comparison cannot confirm any rela2onship between mandatory vaccina2on and rates of childhood immuniza2on in the EU/EEA countries. * In some countries, such as Italy, vaccina0on against pertussis is highly recommended but not compulsory, while those against diphteria and tetanus on the contrary are, but the three are usually administered in one single shot. Methods Informa0on on policies of mandatory or recommended vaccina0ons in the EU/EEA countries were gathered by VENICE project (eurosurveillance.org). Data on childhood immunisa0on coverage in the EU/EEA countries were taken from the UNICEF official website (data.unicef.org).

ASSET dataviz 1 p2 They refer to the period from 2007 to 2013, so that the visualiza0on can show temporal trends in immunisa0on rate in each country, as well. As defined by VENICE project, vaccina0ons are recommended when included in the na0onal immunisa0on programme for all or some specific groups independent of being funded or not. A vaccine is defined as mandatory if every child must receive it by law without the possibility for the parent to choose to accept the uptake or not, regardless of whether a legal or economical implica0on exists for the refusal. Law enforcement and legal consequences may be very different but, since the na0onal contexts are difficult to evaluate, the VENICE survey did not collect any informa0on about them. We chose three relevant vaccina0ons, on which different policies have been adopted in different countries. While polio vaccine is mandatory in many countries, pertussis vaccine is more o]en only recommended, even in countries where other vaccina0ons are compulsory. Measles vaccina0on is an important indicator of hesitancy and refusal, since misinforma0on accusing it of causing au0sm, despite evidence of its fraudulent source, is s0ll going on. Data Visualiza)on In the following maps, one for each vaccine, countries where a vaccina0on is mandatory has been marked with a lined background, while those where the same vaccina0on is recommended have a spo@ed background. Countries coloured in green have had an average higher vaccine coverage than the EU/EEA average evaluated on all the countries over the period considered while the coverage is lower than the average in the blue ones. No evident correla0on between colours and different backgrounds appears from the maps. Pertussis vaccina0on coverage in EU/EEA. Blue/green countries are below/above the European average. Mandatory vaccina0on has been marked with a lined background.

ASSET dataviz 1 p3 Polio vaccina0on coverage in EU/EEA. Blue/green countries are below/above the European average. Mandatory vaccina0on has been marked with a lined background. Measles vaccina0on coverage in EU/EEA. Blue/green countries are below/above the European average. Mandatory vaccina0on has been marked with a lined background. While maps can give a first, general overview at a glance, the following graphs further analyse the situa0on by showing the rates of immuniza0on for Pol3, MCV1 and DTP3 vaccines in all EU/EEA countries from 2007 to 2013. The black line shows the EU/EEA average, evaluated on all the countries, at the 0me, while green and blue areas indicate coverage, respec0vely higher or lower than the average, for each country and each vaccine. The choice of showing the whole 0-100% range in the immuniza0on rates, even if differences are always smaller, highlights countries where the vaccina0on coverage is significantly different from the average.

ASSET dataviz 1 p4 As with previous maps, graphs consider if a vaccine is either mandatory or recommended: for each country, a spo@ed background indicates that a vaccine is recommended, while a lined background indicates that it is mandatory. Discussion This data visualiza0on, showing temporal trends in immunisa0on rates in the EU/EEA countries in the last years for 3 main vaccines, does not suggest any evident rela0onship between vaccina0on coverage and na0onal policies on compulsory vaccina0ons. Some examples from the graphs confirm this idea. On one side, countries where a vaccina0on is mandatory do not usually reach be@er coverage than neighbour or similar countries where there is no legal obliga0on, as one can see comparing both Bal0c and Scandinavian countries. Bal0c countries. Latvia, where vaccina0ons are mandatory, does not reach be@er coverage than other Bal0c countries.

ASSET dataviz 1 p5 Scandinavian countries. Similar countries can show different scenarios despite same policy about recommended vaccina0on. On the other side, similarly nega0ve trends in very different countries, with different policies about compulsory vaccina0on, suggest that other factors could be involved, ie. not only hesitancy in parents, but also difficul0es of healthcare systems in reaching all children. Austria and Romania. Despite different policies about compulsory vaccina0on, Austria and Romania face similarly nega0ve trends in immuniza0on coverage.

ASSET dataviz 1 p6 Conclusion This analysis has some limits. One is the lack of informa0on on possible changes in na0onal vaccina0on policies (recommended or mandatory) over the years, so preven0ng the possibility to understand if, in any case, a different approach could have influenced trends of immunisa0on. Thus, gathering these data will be a key step for future analysis. We analysed data from only three relevant childhood vaccina0ons, assuming that they can reflect a general situa0on of immunisa0on rates in the EU/EEA countries. Anyway, the analysis could be extended to other vaccina0ons in the future. Even if this data visualiza0on cannot provide full evidence of the efficacy or inefficacy of mandatory vaccina0ons on immunisa0on rates, it shows that this approach does not appear to be relevant in determining childhood immunisa0on rate in the EU/EEA countries. Further analysis of maps and graphs could suggest new direc0ons for further inves0ga0on. CONTACTS General inquiries: info@asset-scienceinsociety.eu Main Website: www.asset-scienceinsociety.eu Action plan on Science in Society related issues in Epidemics and Total pandemics Co-funded by EU. GA: 612236.